Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
Jumanne, 14 Julai 2026, 15:55:47 GMT +3
Gastritis management
Gastritis management
Gastritis is an inflammatory mucosal response to injury from a variety of agents and mechanisms, including infections, drugs, alcohol, acute stress, radiation, allergy, acid and bile, ischaemia, or direct trauma.
The inflammation may involve the entire stomach (pangastritis) or a specific region of the stomach (antral gastritis). The severity of inflammation may be erosive or non-erosive.
Clinical presentation
Nausea
Vomiting
Loss of appetite
Belching
Bloating
Acute abdominal pain
Abdominal discomfort
Fever
Chills
Hiccups
Investigations
Endoscopic evidence of gastric mucosal inflammation
Histological evidence of chronic active inflammation on biopsy specimens
Non-pharmacological treatment
Reduce the use of drugs known to cause gastritis (e.g., NSAIDs and alcohol).
Stop smoking.
Reduce fatty, spicy, and deep-fried foods.
Pharmacological treatment
H. pylori eradication
Triple therapy for H. pylori eradication if infection is confirmed.
Refer to the H. pylori eradication section.
Supportive treatment
Administer fluids and electrolytes as required, particularly in patients with vomiting.
Acid suppression therapy
Pantoprazole (IV) 40 mg every 6 hours for 2–3 days
OR
Esomeprazole (IV) 40 mg every 12 hours for 2–3 days
Antiemetic therapy
Metoclopramide (IM) 10 mg every 12 hours when required for cases presenting with intractable vomiting
Step-down therapy
Switch to an oral proton pump inhibitor (PPI) once the patient can tolerate oral intake.
Referral
Refer to the next level of care with appropriate expertise and facilities for complicated cases or patients presenting with alarm features, including:
Anaemia
Haematemesis (vomiting blood)
Weight loss
Refer to the complete list of alarm features under the GERD section.
Imeandikwa:
Jumatatu, 22 Juni 2026, 15:05:26 GMT +3
References:
